Laboratorio Reig Jofre : 2018 02 20 - Reig Jofre informs on the presentation of 2017 results (PDF)
February 20, 2018 at 02:52 am EST
Share
CNMV Edison, 4 28006 Madrid
Barcelona, February 20, 2017
RELEVANT FACT
Dear Sir,
In accordance with Law 24/1988, of July 28, relative to the regulation of the stock markets and related provisions, LABORATORIO REIG JOFRE SA ("Reig Jofre" or "the Company"), informs that on February 28, before the opening of the Spanish stock market, the Company will issue its 2016 results note. Additionally, on Friday, March 2, at 10:00 CET, the Company will give full detail of 2017 results in a presentation to be held at the auditorium of the Madrid Stock Exchange (Plaza de la Lealtad, 1 - Madrid, Spain).
On behalf of Reig Jofre, the presentation will be hosted by:
• Ignasi Biosca, CEO
• Roser Gomila, CFO
RSVP will be appreciated at:investors@reigjofre.com
The presentation will be broadcasted live, in Spanish and English, through Reig Jofre's home page onwww.reigjofre.com
Adolf Rousaud
Secretary of the Board of Directors Laboratorio Reig Jofre SA
Laboratorio Reig Jofre SA published this content on 20 February 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 20 February 2018 07:25:09 UTC.
Original documenthttp://www.reigjofre.com/images/descargas/eng/investors/relevant_facts/2018-2-20-HR-Presentacion-resultados-2017-ing.pdf
Public permalinkhttp://www.publicnow.com/view/177DB6E4030EF2B80B552B7D0F05B2A86CFBFD34
Laboratorio Reig Jofre SA, formerly Natraceutical SA, is a Spain-based company primarily engaged in the research, development, manufacturing and marketing of drugs. The Companyâs activities are divided into four business divisions: Industrial Services, providing production services for third parties; Pharma, selling own pharmaceuticals under a range of brands, such as Reig Jofre, Medea, Orravan, Bioglan and Sala; Reaserch and Development (R&D) and Regulatory, including the development of indications for existing molecules, as well as generics and molecular diagnostics, among others; and Biotech, offering biopharmaceutical support services, such as analytical and process development, quality control and assurance, as well as stability studies. The Company also provides nutritional cosmetics, and food supplements, among others. It operates worldwide in Europe, Africa, the Americas, Australia and Asia through a number of subsidiaries, including Chiesi Espana SA and Oryzon Genomics SA.
LABORATORIO REIG JOFRE, S.A. 
